Co-designing Digital Ulcers Opportunities With Patients and Clinicians
NCT05785403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2023-03-27
Summary
Scleroderma (SSc) is a rare crippling chronic disease associated with damage of the blood vessels and hardening of connective tissue. It has quite a number of complications including ulcers to the fingers and toes (digital ulcers).
Digital ulcers (DU) are a frequent challenge in patients with SSc (PwSSc), as they approximately affect more than half of these patients. Care received by PwSSc DU is varied. Patients with three or more ulcers are considered to have severe disease therefore these patients usually receive expensive treatments and referred to specialist SSc clinics, while those with less ulcers may not receive the same treatments, and only see their general practitioner or local rheumatologist or left to their own means. Resulting in patients developing their own DU managing practices which may be good and some not.
Currently, no research has fully identified the needs of PwSSc DU and self-care interventions to support them are lacking. The extent to which DU support needs are met by non-specialist health professionals is unknown. There is lack of literature in co-designing interventions with patients in SSc DU. Developing interventions and pathways for managing DU with patients and healthcare professionals (HCP) will enhance DU care and lessen the burden for the affected patients, a qualitative study is required.
Aim The aim of this research is to co-design self-care opportunities and develop improvements in DU care.
Objectives
1. to explore how patients with SSc DU are currently managed
2. to understand how they currently manage their ulcers and their healthcare needs.
3. to collaboratively co-design self-care opportunities and improvements in care.
Study Methods Experience-based co-design (EBCD) qualitative methodology will be used to conduct the study. 10 HCP and 12-15 PwSSc DU will be invited to participate in consultation observations. Followed by individuals interviews for the HCP and PwSSc DU care and perceptions on unmet needs. The results will inform collaborative co-designing and development of interventions with patients and HCP. The same participants will also be invited to participate in three workshops involving designing, discussion, refinement and finalisation of the interventions. The interventions developed will be ready to be tested or being evaluated once they have been put in place..
Conditions
- Scleroderma
- Scleroderma Associated Digital Ulcer
- Digital Ulcer
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Royal Free Hospital NHS Foundation Trust
collaborator OTHER - lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-30
- Primary Completion
- 2023-12-31
- Completion
- 2024-06-30
More Related Trials
-
Scleroderma Registry & Repository at the Hospital for Special Surgery
NCT01656447 ·Status: RECRUITING
-
Pragmatic Clinical Trials in Scleroderma
NCT03610217 ·Status: UNKNOWN ·Phase: NA
-
International Pachyonychia Congenita Research Registry
NCT02321423 ·Status: RECRUITING
-
Lower Urinary Tract Symptoms in Systemic Sclerosis
NCT01971294 ·Status: COMPLETED
-
The Effects of Exercise in Patients With Systemic Sclerosis
NCT03058887 ·Status: COMPLETED ·Phase: NA
-
Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers
NCT03406988 ·Status: UNKNOWN ·Phase: NA
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis
NCT00843102 ·Status: COMPLETED
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.
NCT02615964 ·Status: COMPLETED
-
CSL Behring Sclero XIII
NCT02551042 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc
NCT04826419 ·Status: COMPLETED ·Phase: NA
-
Metabolomic Analysis of Systemic Sclerosis
NCT02298777 ·Status: TERMINATED
-
Digital Ulceration
NCT01377090 ·Status: COMPLETED
-
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226 ·Status: RECRUITING ·Phase: NA
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA
-
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
NCT04265144 ·Status: RECRUITING ·Phase: NA
-
Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
NCT00624273 ·Status: COMPLETED ·Phase: PHASE2
-
Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis
NCT05204784 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
NCT00077584 ·Status: COMPLETED ·Phase: PHASE3
-
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072 ·Status: RECRUITING
-
Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers
NCT02801305 ·Status: COMPLETED ·Phase: PHASE2
-
Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of Scleredema
NCT04335396 ·Status: UNKNOWN
-
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA